![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Genizon Announces Milestone in Identifying Genes in Psoriasis
Genizon Announces Milestone in Identifying Genes in Psoriasis
Genizon BioSciences announced the confirmation of a previously reported disease-gene location, PSORS1, as well as the identification of more than 10 new regions strongly associated with psoriasis, each containing only a limited number of genes. The company will be discussing with potential pharmaceutical partners how these discoveries can translate into new therapeutics and diagnostics, leading to a Personalized Medicine approach to this disease, an approach advocated by the U.S. FDA.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-21-2005/0003441591&EDATE=)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct